Issue 3/2008
Content (22 Articles)
The future of mammary stem cell biology: the power of in vivo transplants
Geoffrey J Lindeman, Jane E Visvader, Matthew J Smalley, Connie J Eaves
The future of mammary stem cell biology: the power of in vivotransplants – authors' response
Gilbert H Smith, Daniel Medina
Antiproliferative and cytostatic effects of the natural product eupatorin on MDA-MB-468 human breast cancer cells due to CYP1-mediated metabolism
Vasilis Androutsopoulos, Randolph RJ Arroo, John F Hall, Somchaiya Surichan, Gerry A Potter
Autoantibodies as potential biomarkers for breast cancer
Li Zhong, Kun Ge, Jin-chi Zu, Long-hua Zhao, Wei-ke Shen, Jian-fei Wang, Xiao-gang Zhang, Xu Gao, Wanping Hu, Yun Yen, Kemp H Kernstine
Breast cancer tumor growth estimated through mammography screening data
Harald Weedon-Fekjær, Bo H Lindqvist, Lars J Vatten, Odd O Aalen, Steinar Tretli
Intact and total insulin-like growth factor-binding protein-3 (IGFBP-3) levels in relation to breast cancer risk factors: a cross-sectional study
Caroline Diorio, Jacques Brisson, Sylvie Bérubé, Michael Pollak
Estrogen and progesterone induce persistent increases in p53-dependent apoptosis and suppress mammary tumors in BALB/c-Trp53+/-mice
Karen A Dunphy, Anneke C Blackburn, Haoheng Yan, Lauren R O'Connell, D Joseph Jerry
TIMP-2 mediates the anti-invasive effects of the nitric oxide-releasing prodrug JS-K in breast cancer cells
Ann-Marie Simeone, Vanity McMurtry, René Nieves-Alicea, Joseph E Saavedra, Larry K Keefer, Marcella M Johnson, Ana M Tari
Serum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancer
Brian M Nolen, Jeffrey R Marks, Shlomo Ta'san, Alex Rand, The Minh Luong, Yun Wang, Kimberly Blackwell, Anna E Lokshin
Alternative splicing and the progesterone receptor in breast cancer
David MW Cork, Thomas WJ Lennard, Alison J Tyson-Capper
Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors
Eiji Sunami, Masaru Shinozaki, Myung-Shin Sim, Sandy L Nguyen, Anh-Thu Vu, Armando E Giuliano, Dave SB Hoon
Are the so-called low penetrance breast cancer genes, ATM, BRIP1, PALB2 and CHEK2, high risk for women with strong family histories?
Graham B Byrnes, Melissa C Southey, John L Hopper
Effects of common germline genetic variation in cell cycle control genes on breast cancer survival: results from a population-based cohort
Elizabeth M Azzato, Kristy E Driver, Fabienne Lesueur, Mitul Shah, David Greenberg, Douglas F Easton, Andrew E Teschendorff, Carlos Caldas, Neil E Caporaso, Paul DP Pharoah
Surface-enhanced laser desorption/ionization time-of-flight proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression
Kristyna Brozkova, Eva Budinska, Pavel Bouchal, Lenka Hernychova, Dana Knoflickova, Dalibor Valik, Rostislav Vyzula, Borivoj Vojtesek, Rudolf Nenutil
Expression of the epidermal growth factor receptor (EGFR) and the phosphorylated EGFR in invasive breast carcinomas
Christina Magkou, Lydia Nakopoulou, Christina Zoubouli, Kanelina Karali, Irene Theohari, Panagiotis Bakarakos, Ioanna Giannopoulou
Mammary carcinoma behavior is programmed in the precancer stem cell
Patrizia Damonte, J Graeme Hodgson, Jane Qian Chen, Lawrence JT Young, Robert D Cardiff, Alexander D Borowsky
Jab1 is a target of EGFR signaling in ERα-negative breast cancer
Jiaxu Wang, Rebecca O Barnes, Nathan R West, Melanie Olson, Jenny E Chu, Peter H Watson
Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells
Matthew J Grimshaw, Lucienne Cooper, Konstantinos Papazisis, Julia A Coleman, Hermann R Bohnenkamp, Laura Chiapero-Stanke, Joyce Taylor-Papadimitriou, Joy M Burchell
SELDI-TOF proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression
Bashar A Zeidan, Paul A Townsend
The CD44+/CD24-phenotype is enriched in basal-like breast tumors
Gabriella Honeth, Pär-Ola Bendahl, Markus Ringnér, Lao H Saal, Sofia K Gruvberger-Saal, Kristina Lövgren, Dorthe Grabau, Mårten Fernö, Åke Borg, Cecilia Hegardt
PMC42, a breast progenitor cancer cell line, has normal-like mRNA and microRNA transcriptomes
Anna Git, Inmaculada Spiteri, Cherie Blenkiron, Mark J Dunning, Jessica CM Pole, Suet-Feung Chin, Yanzhong Wang, James Smith, Frederick J Livesey, Carlos Caldas